AMEX · Biotechnology

CLDI (CLDI) Stock

$0.11 +0.18% AMEX: CLDI Healthcare

Valuation

MetricValue
Price$0.11
Market Cap$802266
P/E Ratio-0.03
P/B Ratio0.32
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$19.20
52-Week Low$0.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-700.65%
ROA-1.10%
ROCE-500.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.46
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-10.0M$-23.0M$-29.0M$-22.0M$-20.0M
Net Profit$-11.0M$-25.0M$-29.0M$-22.0M$-20.0M
EPS$14.16$-358.80$-207.61$-35.70$-5.95
Op Margin-2334.5%-51395.6%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.0M$3.0M$10.0M$14.0M$9.0M
Total Liabilities$26.0M$53.0M$18.0M$12.0M$5.0M
Cash$2.0M$0$2.0M$10.0M$6.0M
Borrowings$5.0M$6.0M$7.0M$7.0M$3.0M

Latest News

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers GlobeNewswire · Jul 21, 2026 Calidi Biotherapeutics to Effect 1-for-16 Reverse Stock Split MT Newswires · Jul 20, 2026 Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026 GlobeNewswire · Jul 20, 2026 Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 GlobeNewswire · Jul 8, 2026 Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit GlobeNewswire · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-13.0M$-27.0M$-20.0M$-21.0M
Investing Cash Flow$0$-1.0M$-1.0M$0$0
Financing Cash Flow$8.0M$0$1.0M$9.0M$-1.0M
Net Cash Flow$2.0M$-1.0M$2.0M$8.0M$-4.0M
Free Cash Flow$-8.0M$-14.0M$-28.0M$-20.0M$-21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.05
FCF Yield-1549.06%
Quick Ratio1.92
Interest Coverage—
Return 1Y-98.21%
Return 3Y-99.99%
Return 5Y—

Ownership

Insiders Held1.87%
Institutions Held10.46%
Institutions Float Held10.66%
Institutional HolderSharesReport Date
Armistice Capital, LLC879,0002026-03-31
Sabby Management, LLC434,9032026-03-31
Warberg Asset Management LLC250,0002026-03-31
HighTower Advisors, LLC83,5232026-03-31
Virtu Financial LLC75,7692026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CMND $1.62 +0.52% -0.79 $2.41M 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%
KZIAKazia Therapeutics Ltd ADR $14.54 +2.76% -2.01 $23.55M 0.00%
QLGNQualigen Therapeutics, Inc. $3.21 +5.59% -0.45 $5.43M 0.00%

About CLDI

CLDI is led by CEO Eric E. Poma, employs 28 people, headquartered in US, publicly traded since 2021.

CLDI stock trades at $0.11 with a market capitalization of $802266. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of 0.32, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.10 and $19.20, and currently trades 99.4% below its 52-week high.

On profitability, CLDI generates a return on equity (ROE) of -700.65%, return on capital employed of -500.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides